POLYPHARMACY IN ELDERLY PATIENTS: A REVIEW

  • Meenakumari Amanacharla Guntur Medical College, Kannavarithota, Guntur, Andhrapradesh, India.
  • Raghunatha Rao Ponnaluri Guntur Medical College, Kannavarithota, Guntur, Andhrapradesh, India.

Abstract

Patients above 65yrs of age often present with multiple diseases requiring treatment with more number of drugs which is referred to as polypharmacy. Due to age related changes in the pharmacokinetic & pharmacodyamic parameters, elderly patients may present with adverse drug events, drug interactions and hospitalization resulting in increased morbidity. The aim of our study is to assess the various causes and effects of multiple medications and find measures to reduce and manage polypharmacy. Materials for this review were gathered from medline database. The causes for polypharmacy include multiple comorbidities, multiple hospital visits, consuming over the counter medications and herbal products. Risk of falls is found to increase with polypharmacy and  treatment with cardiovascular and psychoactive drugs. With increase in the number of drugs the risk of adverse drug reactions and drug interactions is more. Increase in the medical expenditure and non adherence with the drugs has been associated with polypharmacy. Hence there is a need to evaluate  polypharmacy by following various criteria or tools and manage treating the elderly in an effective manner

Key words : polypharmacy, multiple medications, elderly adults, geriatric
Keywords: polypharmacy, multiple medications, elderly adults, geriatric

Downloads

Download data is not yet available.

Author Biographies

Meenakumari Amanacharla, Guntur Medical College, Kannavarithota, Guntur, Andhrapradesh, India.

Guntur Medical College, Kannavarithota, Guntur, Andhrapradesh, India.

Raghunatha Rao Ponnaluri, Guntur Medical College, Kannavarithota, Guntur, Andhrapradesh, India.
Guntur Medical College, Kannavarithota, Guntur, Andhrapradesh, India.

References

1. Arch Intern Med. 2004 Oct 11; 164(18):1957-9. Polypharmacy: a new paradigm for quality drug therapy in the elderly? Gurwitz JH.
2. Kennerfalk A., Ruigomez A., Wallander M.A., Wilhelmsen L.,Johansson S. Geriatric drug therapy and healthcare utilization in the United kingdom. Ann. Pharmacother. (2002) 36 797–803
3. Med J Aust. 2012 Jan 16; 196(1):50-3. A national census of medicines use: a 24-hour snapshot of Australians aged 50 years and older. Morgan TK1, Williamson M, Pirotta M, Stewart K, Myers SP, Barnes J.
4. Stewart, R.B. Polypharmacy in the elderly: a fait accompli?. DICP. 1990;24:321–323. PubMed
5. Clin Geriatr Med. 1992 Feb;8(1):143-58. Overcoming problems with polypharmacy and drug misuse in the elderly. Montamat SC, Cusack B.
6. Clin Pharmacol Ther. 2009 Jan;85(1):86-8. doi: 10.1038/clpt.2008.224. Epub 2008 Nov The effects of polypharmacy in older adults. Hilmer SN, Gnjidic D.
7. Polypharmacy and Aging ; Is there cause for Concern? Lisa Pervin, Phd RN CRRN Gerontology Update ARN Network Feb/March 2008
8. Clin Pharmacol Ther. 2009 Jan;85(1):86-8. doi: 10.1038/clpt.2008.224. Epub 2008 Nov 26.The effects of polypharmacy in older adults. Hilmer SN, Gnjidic D
9. Lancet. 2007 Jul 14;370(9582):185-91. The challenge of managing drug interactions in elderly people. Mallet L, Spinewine A, Huang A.
10. The Relationship between Number of Drugs and Potential Drug-Drug Interactions in the Elderly A Study of Over 600 000 Elderly Patients from the Swedish Prescribed Drug Register Kristina Johnell 1,2 and Inga Klarin1,2,3
11. Lindblad CI, Hanlon JT, Gross CR, et al. Clinically important drug- disease interactions and their prevalence in older adults. Clin Ther. 2006; 28:1133–43. [PubMed: 16982290
12. Akazawa M, Imai H, Igarashi A, Tsutani K. Potentially inappropriate medication use in elderly Japanese patients. Am J Geriatr Pharmacother. 2010; 8:146–160. [PubMed: 20439064]
13. Hovstadius B, Petersson G. The impact of increasing polypharmacy on prescribed drug expenditure-a register-based study in Sweden 2005-2009. Health Policy. 2013; 109:166–74. [PubMed: 23195435]
14. Bourgeois FT, Shannon MW, Valim C, et al. Adverse drug events in the outpatient setting: an 11-year national analysis. Pharmacoepidemiol Drug Saf. 2010; 19:901–10. [PubMed: 20623513
15. Marcum ZA, Amuan ME, Hanlon JT, et al. Prevalence of unplanned hospitalizations caused by adverse drug reactions in older veterans. J Am Geriatric Soc. 2012; 60:34–41
16. Predicting nursing home admission in the U.S: a meta-analysis Joseph E Gaugler*, Sue Duval, Keith A Anderson and Robert L Kane
17. Br J Clin Pharmacol. 2006 Feb;61(2):218-23. Polypharmacy and falls in the middle age and elderly population. Ziere G, Dieleman JP, Hofman A, Pols HA, van der Cammen TJ, Stricker BH.
18. Tromp AM, Plujim SM, Smit JH, et al. Fall-risk screening test: a positive study of predictors for falls in community-dwelling elderly. J Clin Epidemiol. 2001; 54:837–844. [PubMed: 11470394]
19. J Am Geriatr Soc. 1999 Jan;47(1):30-9. Drugs and falls in older people: a systematic review and meta-analysis: I. Psychotropic drugs. Leipzig RM, Cumming RG, Tinetti ME. Ref : J Am Geriatr Soc. 1999 Jan;47(1):40-50.
20. Drugs and falls in older people: a systematic review and meta-analysis: II. Cardiac and analgesic drugs. Leipzig RM, Cumming RG, Tinetti ME.
21. Hajjar ER, Cafiero AC, Hanlon JT. Polypharmacy in elderly patients. Am J Geriatr Pharmacother. 2007; 5:345–51. [PubMed: 18179993]
22. Clinical pharmacology in the geriatric patient Sarah N. Hilmera *, Andrew J. McLachlanb,c , David G. Le Couteurb
23. ARMOR : A tool evaluate polypharmacy un elderly persons , Raza Haque, MD Annauls of Long term care June 2009.
Statistics
164 Views | 189 Downloads
How to Cite
1.
Amanacharla M, Ponnaluri R. POLYPHARMACY IN ELDERLY PATIENTS: A REVIEW. JDDT [Internet]. 13Mar.2015 [cited 7Jul.2020];5(2):17-9. Available from: http://jddtonline.info/index.php/jddt/article/view/1082